...vaccine to treat and prevent HBV infection using Mologen's MIDGE DNA vectors against HBV and Synvolux's...
...portion. IP ownership resulting from the deal was not disclosed. Mologen AG (Xetra:MGN), Berlin, Germany Synvolux Therapeutics B.V....

...I/II testing to treat RCC this year. Separately, MGN received exclusive, worldwide rights to use Synvolux's...
...not disclosed. Mologen AG (FSE:MGN), Berlin, Germany Onco Life Sciences Pvt. Ltd. , Pune, India Synvolux Therapeutics B.V....